University of Cincinnati

03/23/2026 | Press release | Distributed by Public on 03/23/2026 11:23

Struggling with daily HIV meds

Struggling with daily HIV meds?

UC researcher says monthly shots may be the answer

3 minute read March 23, 2026 Share on facebook Share on Twitter Share on LinkedIn Share on Reddit Print StoryLike

For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain.

As yahoo! health recently reported, a new study suggests there may be a better option.

"We saw that there is a cadre of individuals who consistently are struggling," said Carl Fichtenbaum, MD, a University of Cincinnati College of Medicine researcher who worked on the study. UC was one of the sites that enrolled patients.

Fichtenbaum, a professor of clinical medicine in the Division of Infectious Diseases in the Department of Internal Medicine, said the gap urged the research team to "look for other solutions." Long-acting injections may be one of them.

Researchers found that long-acting injections given once a month helped people stay on treatment far more consistently than daily pills, cutting treatment failure nearly in half among patients who had previously struggled to keep up with medication.

The study, published in the New England Journal of Medicine, involved 453 people living with HIV who had a history of difficulty sticking to daily treatment. After helping participants stabilize on oral medication, researchers randomly assigned some to remain on pills and others to switch to monthly injections of cabotegravir and rilpivirine.

People taking daily pills fell off their treatment plans nearly twice as often as those receiving injections, researchers found.

Global health experts agree that HIV care today is highly effective, but only if people can stay on it. Treatment suppresses the virus, protects the immune system and prevents transmission. Missing doses, even intermittently, can allow the virus to rebound, making it more difficult for the body to resist infection and some cancers.

People fall out of care for all kinds of reasons: forgetting doses, struggling to afford and access prescriptions, or avoiding pharmacies and clinics because of stigma. For people dealing with mental health conditions or substance use, the challenges can be even greater.

Read the full yahoo! health article.

Featured image at top: iStock/SyhinStas.

Related Stories

1

'Paradigm-shifting' study confirms effectiveness of long-acting HIV treatment

February 26, 2026

The results of a clinical trial involving the University of Cincinnati, recently published in The New England Journal of Medicine, show people failing HIV treatments with oral medications were able to be treated successfully using injections.

2

UC study: New treatment guidelines needed for chronic kidney disease patients

February 3, 2026

A recently published study from the University of Cincinnati College of Medicine emphasizes the need for new treatment guidelines in the U.S. on reproductive health among patients with chronic kidney disease (CKD).

3

UC receives grant for AI use in medical education

February 26, 2026

The University of Cincinnati is turning to artificial intelligence to help solve a problem in medical training. The College of Medicine was awarded a grant valued at more than $1 million to use AI in advanced physician training through personalized learning.

University of Cincinnati published this content on March 23, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 23, 2026 at 17:23 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]